3DSF | Immune System | date | Jul 12, 2008 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Anti-Osteopontin Antibody 23c3 In Compl W43a Mutated Epitope Peptide | ||||||||||||||
authors | J.Du, C.Zhong, H.Yang, J.Ding | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Fab Fragment Of Anti-Osteopontin Antibody 23c3, L Chain; Chain: L |
Organism_scientific: Mus Musculus Organism_common: Mouse Organism_taxid: 10090 Tissue: Ascites | ||||||||||||||
Molecule: Fab Fragment Of Anti-Osteopontin Antibody 23c3, H Chain; Chain: H |
Organism_scientific: Mus Musculus Organism_common: Mouse Organism_taxid: 10090 Tissue: Ascites | ||||||||||||||
Molecule: A Peptide From Osteopontin Chain: P Engineered: Yes |
Synthetic: Yes Other_details: The Peptide Vatalnpdpsqk Is Synthesized At S Hd Bioscience Company | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.80 Å | ||||||||||||
ligand | BMA, MAN, NAG | enzyme |
| ||||||||||||
Primary reference | Molecular basis of recognition of human osteopontin by 23C3, a potential therapeutic antibody for treatment of rheumatoid arthritis., Du J, Hou S, Zhong C, Lai Z, Yang H, Dai J, Zhang D, Wang H, Guo Y, Ding J, J Mol Biol. 2008 Oct 17;382(4):835-42. Epub 2008 Jul 31. PMID:18694758 |
Data retrieval |
View 3DSF in 3D |
Visual 3D analysis of 3DSF |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3DSF |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |